Saltar al contenido
Merck

Standardizing GC-MS metabolomics.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2008-06-10)
Harin Kanani, Panagiotis K Chrysanthopoulos, Maria I Klapa
RESUMEN

Metabolomics being the most recently introduced "omic" analytical platform is currently at its development phase. For the metabolomics to be broadly deployed to biological and clinical research and practice, issues regarding data validation and reproducibility need to be resolved. Gas chromatography-mass spectrometry (GC-MS) will remain integral part of the metabolomics laboratory. In this paper, the sources of biases in GC-MS metabolomics are discussed and experimental evidence for their occurrence and impact on the final results is provided. When available, methods to correct or account for these biases are presented towards the standardization of a systematic methodology for quantitative GC-MS metabolomics.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Supelco
N-Metil-N-(trimetilsilil)trifluoroacetamida, synthesis grade
Supelco
N-Metil-N-(trimetilsilil)trifluoroacetamida, BioReagent, for silylations, LiChropur
Supelco
N-Metil-N-(trimetilsilil)trifluoroacetamida, for GC derivatization, LiChropur, ≥98.5%
Supelco
N-Metil-N-(trimetilsilil)trifluoroacetamida, ampule of 10 × 1.2 mL, analytical standard, Cerilliant®
Supelco
N-Methyl-N-(trimethylsilyl)trifluoroacetamide with 1% trimethylchlorosilane, for GC derivatization, LiChropur